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Available online 16 September 2011AbstractBackground: Somatostatin receptors (SSTRs) have been proven to be involved in cardioprotection, but the effects of mechanical stress on their
expression remain to be elucidated.
Aim: To investigate whether mechanical stretch is associated with increased expression of the SSTR in cardiomyocytes and if the phenomenon is
mediated via an angiotensin II signaling pathway.
Methods: Using a well established cyclic mechanical stretch model exerting strain on primary cultured neonatal Wistar rat cardiomyocytes, we
studied the expression of major SSTRs of cardiomyocyte under such stress. Western blot and immunoprecipitation were used to demonstrate
the related changes. The role of endogenous angiotensin II and the effects of AT-1 receptor blockade were studied by pre-administration of
losartan.
Results: Northern and western blotting revealed progressive increase of SSTR-1 mRNA and protein expression as the duration of stretch
increased up to 48 hours. The maximal increases of SSTR-1 mRNA and protein were observed at 24 hours. The mechanical stretch
significantly increased the angiotensin II in cardiomyocytes concomitantly. Losartan and PD98059 had a significant inhibitory effect on the
expression of SSTR-1, indicating the angiotensin II and p42/p44 MAP kinases-related pathways were involved in the expression of SSTR-1
under mechanical stress. By contrast, tyrosine kinases, protein kinase A, protein kinase C, JAK-2, JNK and phosphoinositol-3-kinases had no
effect.
Conclusion: This study demonstrated that accentuating the expression of SSTR-1mechanical stretch is angiontensin II and p42/p44 MAP
kinases-dependent.
Copyright  2011, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Hypertensive cardiac disease is a common condition that
emergency physicians have to deal with. Prolonged, uncon-
trolled hypertension always results in left ventricular hyper-
trophy, which is subsequently related to myocardial ischemia,* Corresponding author. Department of Emergency Medicine, Shin-Kong
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doi:10.1016/j.jacme.2011.07.004malignant arrhythmia and sudden cardiac death.1,2 The under-
lying mechanism of myocardial hypertrophy and remodeling is
multifactorial and involves multiple proto-oncogenes, growth
factors, cytokines and extracellular matrices.3e8 However,
increased internal force to the myocardium might be the major
contributing factor.
Although mechanical stress is responsive for myocardial
hypertrophy, the possible candidate mediators or signaling
pathways were investigated. Mechanical stress has been proven
to be closely linkedwith themaintenance ofmyocardial structure
and function. Progressive elevation of mechanical force affectsMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
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components of the myocardium and transforms the physical
properties of the tissues.911 Increased physical stressmight lead
to maladaptive remodeling in many important clinical condi-
tions, such as hypertension, ischemia or contractile abnormali-
ties,12,13 whereas cellular and extracellular remodeling tend to
occur concomitantly and results in pathological processes.14
Among many mediators, somatostatin (SST) and its recep-
tors (SSTR) have been proven to be expressed in myocardium.15
It is well known that SST is produced by various cells, including
cardiomyocytes in response to neuropeptides, neurotransmit-
ters, thyroid and steroid hormones, growth factors and cyto-
kines.15 An earlier study demonstrated that SST affects
contractile responses of atrial and ventricular cardiomyocytes.16
Besides, our data revealed that an SSTanalog could mimic acute
ischemic preconditioning in a rat myocardial infarctionmodel.17
Whether mechanical stress can affect expression of the SSTRs
in myocardium deserves further investigation.
SSTR was considered to play an important role in cardiac
hypertrophy in patients with acromegaly that is associated
with excessive GH secretion.18 However, there is no report
concerning the relationship between SSTR and other patho-
logical conditions associated with cardiac hypertrophy, such as
hypertension. To elucidate the problem, we chose to use a well
established cyclic mechanical stretch model to evaluate its
effect on SSTR expression and to understand the possible
cellular mechanisms involved.
2. Methods2.1. Primary culture of neonatal rat cardiomyocytesNeonatal cardiomyocytes were obtained from 2e3-day-old
Wistar rats by trypsinization. Fetal hearts were excised and
washed in phosphate-buffered saline (PBS). The tissue was
minced and digested repeatedly in a pancreatin solution. The
first two supernatants were discarded and cells released into the
remaining supernatants were maintained at 37C in a 5% CO2/
95% O2 atmosphere in heart medium (Hank’s buffered salt
solution, MEM vitamins, MEM essential amino acids, MEM
nonessential amino acids, 2 mM L-glutamine, 0.05% (w/v)
glycine, 0.0125% hypoxanthine, 50 IU/mL penicillin, 50 mg/mL
streptomycin, 1.65 mg/L sodium bicarbonate and 10% (v/v) fetal
calf serum) until digestion was complete. The cultures were then
enriched for myocytes by plating for 1 hour, to deplete the
culture of non-muscle cells, which adhere more rapidly. Cardiac
myocytes in the medium were then plated into six-well culture
plates (Flex I, Flexcell Co., MaKeesport, PA, USA) at a cell
density of 1.6  103 cells/well. After 2 days in culture, cells
were transferred to serum-free medium (Ham’s F-12/DMEM
1:1 (v/v)) and maintained for another 2 days. The cultured
myocytes obtained were>95% pure as judged by observation of
contractile characteristics with a light microscope and staining
with anti-desmin antibody. The enriched myocytes were sub-
jected to cyclical stretch.
The animals were cared for according to the Guide for the
Care and Use of Laboratory Animals (NIH publication no.85023, revised 1996), and the protocol was approved by our
Institute Review Board.2.2. In vitro cyclical mechanical stretchThe experiment was done with a cyclical strain unit
(Flexcell I FX-2000, Flexcell International Co., PA, USA) that
consisted of a vacuum unit linked to a valve controlled by
a computer program. Neonatal cardiomyocytes cultured on
plates with a flexible membrane base coated with type 1 rat
collagen were subjected to cyclical strain. A pressure of
w15 kPa was applied repeatedly to the flexible baseplate
membrane at 60 cycles/min. Application of the reduced
pressure resulted in maximal elongation of 20% of cells at the
periphery of the well, with strain declining toward the center
of the well. The cardiomyocytes were stretched at 37C in
a humidified incubator with a 5% CO2/95% O2 atmosphere.2.3. RNA isolation and northern blot analysisTotal RNA was isolated from cardiomyocytes by solubl-
izing cardiomyocytes with the Ultraspec RNA kit (BIOTECX
Laboratory, Houston, TX, USA). The cells were washed three
times with PBS at 4C and whole-cell RNA was isolated.
RNA was quantified as the ratio of the absorbance at 260 nm
(A260) and at 280 nm (A280) in a spectrophotometer (U-2010,
HITACHI Co., Japan), denatured and subjected to electro-
phoresis in 1.0% formaldehyde, 10 Denhardt’s solution,
0.1% (w/v) SDS, 0.2 mg/mL denatured salmon sperm DNA,
10 mM EDTA, 25% 4  RNA, 1 M NaCl, 0.6 M TriseHCl
pH 7.5, 0.18 M NaH2PO4$H2O, 0.24 M Na2HPO4, 0.01 M
sodium pyrophosphate at 42C for at least 2 hours. The
hybridization solution was identical except that it contained
10% dextran sulfate and the labeled probe. Equal quantities
(20 mg) of total RNA were loaded into each lane of
a Hybond-Nþ nylon membrane. The rat cDNA clones for
SSTR-1-5, angiotensinogen and the pTRI-GAPDH (Ambion
Inc., TX, USA) were used, and purified insert DNA was
labeled using Redivue [a-32P]dCTP (Amersham Pharmacia
Biotech Co., NJ, USA) for hybridization in Rapid-hyb buffer
(Amersham, Buckinghamshire, UK) at 65C for 4 hours. Blots
were then washed in 0.1% SDS and 0.2  standard saline
citrate at 65C. Quantitative analysis was done with a Phos-
phorImager (Molecular Dynamics, Sunnyvale, CA, USA) and
assays were done for at least five times. The primers used are
listed below.
Somatostatin receptor subtype 1 (318 bp PCR product)
sense, 50-ATGGTGGCCCTCAAGGCCGG-30
antisense, 50-CGCGGTGGCGTAATAGTCAA-30
Somatostatin receptor subtype 2 (318 bp PCR product)
sense, 50-TCCTCTGGAATCCGAGTGGG-30
antisense, 50-TTGTCCTGCTTACTGTCACT-30
Somatostatin receptor subtype 3 (332 bp PCR product)
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antisense, 50-CAGGCAGAATATGCTGGTGA-30
Somatostatin receptor subtype 4 (323 bp PCR product)
sense, 50-GCGCGCGGCGACCTACCGGC30
antisense, 50-GCCTGGTGATTTTCTTCTCC-30
Somatostatin receptor subtype 5 (259 bp PCR product)
sense, 50-CTGGTGGGGCCGGCGCCCTC-30
antisense, 50-CCAGGCGGCACAGGACGGGG-302.4. Western blot analysisProtein extracts were obtained from cultures by rinsing the
cells with ice-cold PBS once and with Tris-buffered saline (pH
7.4). Cells were resuspended in cold lysis buffer (150 mmol/L
NaCl, 20 mmol/L TriseHCl pH 7.5, 1 mmol/L EDTA pH 8.0,
0.5% (w/v) sodium deoxycholate, 1% (v/v) Nonidet P-40,
10 mg/mL aprotinin, 10 mg/mL leupeptin and 1 mmol/L phe-
nylmethylsulfonyl fluoride), and cellular debris was removed
by centrifugation at 14,000g for 10 min at 4C. The protein
content of the supernatant was determined by the Bio-Rad
Protein assay kit and an ELISA reader (A595) using bovine
serum albumin as the standard. Equal amounts of protein
extracts (30 mg) were subjected to electrophoresis in SDS 10%
(w/v) polyacrylamide gels and then electroblotted onto nitro-
cellulose membranes, which were incubated overnight in PBS
containing 5% (v/v) skim milk to block nonspecific binding of
the antibody. Proteins of interest were revealed using specific
antibodies (mouse monoclonal anti-SSTR-1 and anti-SSTR-2
antibodies from Chemicon International, Inc., CA, USA) as
indicated (1:1000 dilution) for 1 hour at room temperature,
followed by incubation with a dilution of 1:5000 of horse-
radish peroxidase-conjugated polyclonal anti-rabbit antibody
for 1 hour at room temperature. The membrane was examined
with an enhanced chemiluminescence system (ECL, Amer-
sham Corp., Buckinghamshire, UK) and the signal intensity
was quantified by densitometry. Equal protein loading of the
samples was further verified by staining with glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) specific monoclonal
antibody.2.5. Treatment protocolFig. 1. Representative northern blots for SSTR-1 mRNA levels in neonatal rat
cardiomyocytes subjected to 20% stretch for various lengths of time.To investigate the possible signaling pathways, different
groups of cardiomyocytes were treated with losartan
(200 nM, an angiotensin AT1 receptor inhibitor), octreotide
(1 mg/mL), H89 (10 mM, a protein kinase A inhibitor), for-
skolin (10 mM, an adenylyl cyclase activator), genistein
(40 mM, a tyrosine kinase inhibitor), AG-490 (100 mM,
a specific inhibitor of Janus kinase or JAK-2), PD 98059
(50 mM, an inhibitor of p42/p44 MAP kinase), Go¨6976
(16 nM, a selective protein kinase C inhibitor), SP600125
(25 mM, a c-Jun N-terminal kinase or JNK inhibitor)wortmannin (50 nM, a phosphoinositol-3-kinase inhibitor) at
30 minutes before the stretch.2.6. Measurement of the concentration of angiotensin IICulture media from cardiac myocytes subjected to cyclical
mechanical stretch were collected for the measurement of
angiotensin II. After adding EDTA (to 1 mg/mL) and captopril
(to 10 mM) and subsequent centrifugation at 1000g at 4C for
5 minutes, the supernatant was collected and frozen at 20C.
The level of angiotensin II was measured by a quantitative
sandwich enzyme immunoassay technique using a commercial
kit (Peninsula Laboratories, Inc., Belmont, CA, USA). The
lower limit of detection of angiotensin II was 0.05 ng/mL and
the interassay variation was <5%.2.7. Statistical analysisAll values are expressed as mean  SEM. Data from
densitometry of northern and western blotting were analyzed
by nonlinear regression curve fitting using SSPS 10.0 soft-
ware. Statistical analysis was done with the Student 2-tailed
paired t test or 2-way analysis of variance (ANOVA) fol-
lowed by the Bonferroni test when appropriate. The level of
statistically significant difference was set at p  0.05.
3. Results3.1. Effect of mechanical stretch on SSTR-1 mRNA
expressionA pressure of w15 kPa was applied repeatedly to the
flexible baseplate membrane at 60 cycles/min. Application of
the reduced pressure resulted in maximal elongation of 20% of
cells at the periphery of the well, with strain declining toward
the center. Northern blotting revealed a progressive increase of
SSTR-1 mRNA expression as the duration of stretch increased
up to 24 hours. The maximal increase ( p < 0.01) of SSTR-1
mRNA at 24 hours was 88  12% (Fig. 1).
Other subtypes of SSTR mRNA that could be detected were
SSTR-2 and SSTR-4. However, there no significant increase of
these SSTR mRNAs was induced by cyclical mechanical
Fig. 2. Representative western blots for SSTR-1 protein levels in car-
diomyocytes subjected to 20% stretch for various lengths of time.
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for SSTR-4. No SSTR-3 or SSTR-5 mRNA was detected
before or after mechanical stretch for various lengths of time.3.2. Effect of mechanical stretch on SSTR-1 protein
expressionWestern blotting revealed a progressive increase of SSTR-1
protein expression as the duration of stretch increased up to 48
hours. The maximal increase ( p < 0.001) of SSTR-1 mRNA
was 110  32% at 24 hours (Fig. 2).
SSTR-2 and SSTR-4 mRNAs were detected; however,
there was no significant increase of these SSTR mRNAs
induced by cyclical mechanical stretch. No SSTR-3 or SSTR-
5 mRNA was detectable either before or after mechanical
stretch for various lengths of time.Fig. 3. (A) Western blots for SSTR-1 protein levels in cardiomyocytes subjected
lorsartan, H89, forskolin and genistein; only lorsartan had a significant inhibitory ef
in cardiomyocytes subjected to 20% stretch for 18 hours in the absence or in th
PD98059 had a significant inhibitory effect on the expression of SSTR-1.3.3. Mechanical stretch causes secretion of angiotensin
II from cardiomyocytesThe mechanical stretch significantly increased ( p < 0.001)
angiotensin II in cardiomyocytes; the concentration of angio-
tensin II increased from 29.8  1.2 to 123.4  4.8 pg/mL after
a stretch for 6 hours, which was comparable with our earlier
study.17 No angiotensin II was detected in the conditioned
medium of fibroblasts either under mechanical stress or not.3.4. Signaling mechanisms of stretch-induced SSTR-1
expressionIn the process of investigating the possible signaling path-
ways, cardiomyocytes were treated with losartan (200 nM, an
angiotensin AT1 receptor inhibitor), octreotide (1 mg/mL),
H89 (10 mM, a protein kinase A inhibitor), forskolin (10 mM,
an adenylyl cyclase activator), genistein (40 mM, a tyrosine
kinase inhibitor), AG-490 (100 mM, a specific inhibitor of
Janus kinase or JAK-2), PD 98059 (50 mM, an inhibitor of
p42/p44 MAP kinase), Go¨6976 (16 nM, a selective protein
kinase C inhibitor), SP600125 (25 mM, a JNK inhibitor)
wortmannin (50 nM, a phosphoinositol-3-kinase inhibitor) at
30 minutes before the stretch.
Losartan prevented SSTR-1 expression almost completely
(Fig. 3A), and PD98059 had an inhibitory effect on stretch-
induced expression of SSTR-1 (Fig. 3B). By contrast, treat-
ment with octreotide, H89, forskolin, genistein, AG-490,
Go¨6976, SP600125 or wortmannin had no significant effect
on stretch-induced SSTR-1 expression (Fig. 3A and B). In
summary, the angiotensin II and p42/p44 MAP kinase-relatedto 20% stretch for 18 hours in the absence or in the presence of octreotide,
fect on the expression of SSTR-1. (B) Western blots for SSTR-1 protein levels
e presence of AG-490, Go¨6976, PD98059, SP600125 and wortmannin; only
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mechanical stress whereas other signaling pathways, such as
tyrosine kinases, protein kinase A, protein kinase C, JAK-2,
JNK and phosphoinositol-3-kinases, were not the contrib-
uting mechanisms.
4. Discussion
This study demonstrated that mechanical stretch can accen-
tuate SSTR-1 expression in an angiontensin II and p42/p44
MAP kinase-dependent manner. Tyrosine kinases, protein
kinase A, protein kinase C, JAK-2, JNK and phosphoinositol-3-
kinases are not involved in stretch-induced SSTR-1 expression.
It is well known that mechanical stress is closely linked to the
maintenance of myocardial structure and function.1921 Chronic
elevation of external force influences myocardial signaling
reactivity, alters the balance of forces between different
components of the myocardium and transforms the physical
properties of these tissues.1921 Increased physical stress might
lead to maladaptive remodeling in pathological conditions such
as hypertension and ischemia, or contractile abnormalities that
produce abnormally excessive stress.22,23 Cellular and extra-
cellular remodeling tends to occur concomitantly and these
pathological processes affect each other because there are close
interactions between the cardiomyocytes and the extracellular
matrix.24 Our colleagues have demonstrated that some matrix
metalloproteinases (MMPs) were induced by tumor necrosis
factor-a in a mechanical stretch model of endothelial cells,25
whereas production of tumor necrosis factor-a could be
induced in cardiac fibroblasts.26 Earlier, we demonstrated that
the cyclical mechanical stretch-induced increase of the expres-
sion of cardiac MMP-14 and MMP-2 is angiotensin II-
dependent. The signaling pathways are mediated mainly by
JAK-2 and STAT-1.27 By contrast, the present study demon-
strated that mechanical stretch can accentuate myocardial
SSTR-1 expression with an angiontensin II and p42/p44 MAP
kinase-dependent signaling pathway. This implies that the same
mediator (angiotensin II) can initiate different signaling path-
ways to provoke different physiological effects, including
protein expression.
The actions of SST are mediated by a family of G protein-
coupled receptors of five distinct subtypes, SSTR1e5, that are
encoded by separate genes on different chromosomes. The five
receptors share common signaling pathways, such as the inhi-
bition of adenylyl cyclase, activation of phosphotyrosine phos-
phatase and modulation of mitogen-activated protein kinase
throughG protein-dependentmechanisms. Some of the subtypes
are also coupled to signaling effectors, such as inward rectifying
K1 channels (SSTR-2e5), voltage-dependent calcium channels
(SSTR-1 and -2), a Naþ/Hþ exchanger (SSTR-1), AMPA/
kainate glutamate channels (SSTR-1 and 2), phospholipase
C (SSTR-2 and 5), and phospholipaseA2 (SSTR-4).15 As
mentioned above, mechanical stretch induces expression of
SSTR-1 in neonatal cardiomyocytes. SSTR-1 is reported to be
coupled with Naþ/Hþ exchangers so it might play an important
role in mechanical strain-related ischemic reperfusion injury,
electrophysiological changes (arrhythmias) and even cardiachypertrophy.2833 Furthermore, the involvement of voltage-
dependent calcium channels might contribute to subsequent
arrhythmias.34 SSTR is considered to play an important role in
cardiac hypertrophy in those with acromegaly associated with
excessive GH secretion.35 However, there is still no report
concerning the relationship between SSTR and other patholog-
ical conditions associated with cardiac hypertrophy, such as
hypertension. The results of this study suggest that SSTR-1
is essential in mechanical strain-induced hypertrophy of
cardiomyocytes.
In conclusion, this study demonstrated that the mechanical
stretch-induced increase of SSTR-1 expression is angiontensin
II and p42/p44 MAP kinase-dependent. This observation
elucidates part of the pathophysiological mechanisms of cardiac
hypertrophy, arrhythmias and even heart failure due to long-
term hypertension.Acknowledgments
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